US Mammography Device Market Report 2022 to 2030

US Mammography Device Market Analysis

$ 3999

US mammography device market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The demand for mammography equipment is influenced by early cancer detection, cancer fear, and quality of life after a diagnosis. The major key players in this market are Hologic Inc., Analogic Corporation, Canon Medical Systems Corporation, Fujifilm Corporation, Siemens Healthcare, Toshiba Medical Systems, GE Healthcare, Metaltronica, Koninklijke Philips N.V., Planmed Oy.

ID: IN10USPH326 CATEGORY: Pharmaceuticals GEOGRAPHY: US AUTHOR: Saloni Shah

Buy Now

US Mammography Device Market Analysis Summary

US Mammography Device Market is valued at around $831.6 Mn in 2022 and is projected to reach $1522.3 Mn by 2030, exhibiting a CAGR of 7.85% during the forecast period 2023-2030.

Mammography can be looked on as an X-ray of the breast. It serves as a breast cancer screening tool. Along with normal clinical tests and monthly self-examinations of the breast, mammograms are a crucial part of the early diagnosis of breast cancer. After the age of 40, mammograms must be performed annually, even if the notion of having one makes you feel uneasy. According to the National Cancer Institute Trusted Source, breast cancer is the second most common cancer in women in the United States, after skin cancer.

Your doctor may recommend a screening mammogram as part of a normal procedure to check for cancer or other changes. During this type of test, a machine will take a number of pictures of your breast. If you have a lump or any other breast cancer symptom, your doctor will then advise you to get a diagnostic mammogram. You would probably need a diagnostic mammogram if you have breast implants. Diagnostic mammography is more extensive than screening mammography. It is frequently required to take additional X-rays to get views of the breast in various positions. Any problematic areas might also be enlarged by your radiologist. The demand for mammography equipment is influenced by early cancer detection, cancer fear, and quality of life after a diagnosis. The major key players in this market are Hologic Inc., Analogic Corporation, Canon Medical Systems Corporation, Fujifilm Corporation, Siemens Healthcare, Toshiba Medical Systems, GE Healthcare, Metaltronica, Koninklijke Philips N.V., Planmed Oy.

Market Dynamics

Market Growth Drivers

The primary factors driving the market growth for mammography equipment are the rising prevalence of breast cancer, as well as scientific advancements in the field of breast imaging and expanding efforts to increase breast cancer awareness in the region. The expanding population is also a significant factor in the rising incidence of breast cancer. Mammography gadget sales are significantly impacted by therapy. The mammography devices market will have plenty of potential prospects due to the different technological advancements in the field of mammography devices and rising technical advancements in breast scanning techniques.

Market Restraints

While it is projected that the market for mammography equipment will be constrained from growing due to the tightening of rules governing intervention authorisation and expensive installation costs for breast implant technologies.

Competitive Landscape

Key Players

Hologic Inc.
Analogic Corporation
Canon Medical Systems Corporation
Fujifilm Corporation
Siemens Healthcare
Toshiba Medical Systems
GE Healthcare
Metaltronica
Koninklijke Philips N.V.
Planmed Oy

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

US Mammography Device Market Segmentation

By Product Outlook

Film Screen Systems
Digital Systems
Analog Systems
3D Systems

By Technology Outlook

Breast Tomosynthesis
CAD Mammography
Digital Mammography

By End Users

Hospitals
Specialty Clinics
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.